NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types

Arber, D.A. , Orazi, A. , Hasserjian, R. , Thiele, J., Borowitz, M.J., le Beau, M.M. , Bloomfield, C.D. , Cazzola, M. & Vardiman, J.W. (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 127, 2391–2405. Barbui, T. , Thiele, J., Passamonti, F. , Rumi, E. , Boveri, E. , Ruggeri, M. , Rodeghiero, F. , D’Amore, E.S. G. , Randi, M.L. , Bertozzi, I. , Marino, F. , Vannucchi, A.M., Antonioli, E. , Carrai, V. , Gisslinger, H. , Buxhofer-Ausch, V. , Mullauer, L. , Carobbio, A. , Gianatti, A. , Gangat, N. , Hanson, C.A. & Tefferi, A. (2011) Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. Journal of Clinical Oncology, 29, 3179–3184. Barbui, T. , Thiele, J., Vannucchi, A.M. & Tefferi, A. (2013) Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia. Leukemia, 27, 1953–1958. Gangat, N. , Caramazza, D. , Vaidya, R. , George, G. , Begna, K. , Schwager, S. , van Dyke, D. , Hanson, C. , Wu, W.T. , Pardanani, A. , Cervantes, F. , Passamonti, F. & Tefferi, A. (2011) DIPSS Plus: a refined dynamic international prognostic scoring system for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. Journal of Clinical Oncology, 29, 392–397. Guglielmelli, P., Rotunno, G. , Pacilli, A. , Rumi, E. , Rosti, V. , Delaini, F. , Maffioli, M. , Fanelli, T. , Pancrazzi, A. , Pieri, L. , Fjerza, R. , Pietra, D. , Cilloni, D. , Sant’Antonio, E. , Salmoiraghi, S. , Passamonti, F. , Rambaldi, A. , Barosi, G. , Barbui, T. , Cazzola, M. & Vannucchi, A.M. (2016) Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients. American Journal of Hematology, 91, 918–922. Guglielmelli, P., Pacilli, A. , Rotunno, G. , Rumi, E. , Rosti, V. , Delaini, F. , Maffioli, M. , Fanelli, T. , Pancrazzi, A. , Pietra, D. , Salmoiraghi, S. , Mannarelli, C. , Franci, A. , Paoli, C. , Rambaldi, A. , Passamonti, F. , Barosi, G. , Barbui, T. , Cazzola, M. & Vannucchi, A. M. 2017. Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis. Blood. https://doi.org/10.1182/blood-2017-01761999 [Epub ahead of print] Mudireddy, M. , Barraco, D. , Hanson, C.A. , Pardanani, A. , Gangat, N. & Tefferi, A. (2017) The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia. American journal of hematology, 92, 454–459. Tefferi, A. & Barbui, T. (2017) Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. American journal of hematology, 92, 94–108. Tefferi, A. , Lasho, T.L. , Finke, C. , Elala, Y. , Barraco, D. , Hanson, C.A. , Ketterling, R.P., Pardanani, A. & Gangat, N. (2015) Targeted nextgeneration sequencing in polycythemia vera and essential thrombocythemia. Blood, 126, 354–354. Thiele, J., Kvasnicka, H.M. , Facchetti, F. , Franco, V. , van der Walt, J. & Orazi, A. (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica, 90, 1128–1132.